Percutaneous Balloon Valvuloplasty: A New Method for Treating Congenital Pulmonary-Valve Stenosis

Kan, Jean S.; White, Robert I.; Mitchell, Sally E.; Gardner, Timothy J.

doi:10.1056/nejm198208263070907

Cited by 660 publications

(241 citation statements)

References 10 publications

Supporting

Mentioning

215

Contrasting

Unclassified

Order By: Relevance

“…Bu işlem, çocuklarda ilk kez uygulanan kardiyak girişimsel tedavi yöntemidir. İlk defa 1982 yılında Kan ve arkadaşları tarafından sekiz yaşındaki bir çocuğa başarılı bir şekilde uygulanmıştır (10). Ülkemizde de 1989 yılından beri birçok pediatrik kardiyoloji merkezinde PBV işlemi uygulanmaktadır (11)(12)(13)(14)(15).…”

Section: Resim 4: Hastanın Tele Görüntüsünde Pulmoner Konus Belirgin unclassified

Pulmoner balon valvüloplasti yapılan çocuklarda kalp kateterizasyonu sonuçlarının değerlendirilmesi

Çimen¹,

Arslan²,

Aslan³

et al. 2014

GenelTipDer

View full text Add to dashboard Cite

Amaç: Bu çalışmada, çocuk kardiyoloji kliniğimizde üç yıl boyunca pulmoner balon valvüloplasti işlemi yapılan çocuklarla ilgili klinik deneyimlerimizin paylaşılması ve sonuçlarının değerlendirilmesi amaçlandı . Gereç ve yöntem: Bu retrospektif çalışmaya, Kasım 2010-Kasım 2013 tarihleri arasında pulmoner balon valvüloplasti işlemi uygulanmış olan çocuklar dahil edildi. Hastalardan sendromik olan yoktu. Pulmoner balon valvüloplasti işlemi, hastalar kateterizasyon laboratuarında genel anestezi altında entübe edilerek gerçekleştirildi. Bulgular: Çalışmaya yedisi kız, altısı erkek 13 hasta dahil edildi. Hastaların ortalama yaşı 2.9±3.74 yıl, yaş aralığı dört günlük-10 yaş arasında idi. Pulmoner darlık 10 hastada valvüler tipte olmasına karşılık, üç hastada valvüler ve infundibuler darlık birlikteydi. İşlemde monofoil kateterler kullanıldı, kateterlerin ortalama çapı 12.2 mm (6-20 mm) idi. Balon/anülüs çap oranı ortalaması 1.21 (1.1-1.33) olarak hesaplandı. Kalp kateterizasyonu sırasında pulmoner kapak üzerinde ölçülen basınç gradiyenti, işlem öncesinde ortalama 75 mmHg (40-120 mmHg), işlem sonrasında ise ortalama 36.4 mmHg (0-95 mmHg) olarak ölçüldü. Hastalara ortalama üç kere (2-5) dilatasyon yapıldı. Hastalardan dördünde darlık gradiyentinde anlamlı bir düşüş olmadığı için hastalar operasyona verildi, bir hastaya ise takiplerinde rezidü darlık geliştiğinden dolayı ikinci kere balon valvüloplasti işlemi yapıldı. Dört hastada (% 30) hafif pulmoner yetmezlik tespit edildi, başka majör veya minör bir komplikasyon gelişmedi. Sonuç: Pulmoner balon valvüloplasti işlemi, pulmoner kapak darlıklarında, her yaştaki hastada ilk tedavi seçeneğidir. Güvenli ve etkili bir işlemdir. Balon/anülüs çap oranı 1.2-1.4 arasında olursa; başarı şansı daha yüksek ve komplikasyon gelişme ihtimali daha düşüktür. Anahtar sözcükler: Pulmoner darlık, pulmoner balon valvüloplasti, klinik sonuçlarEvaluation of the results of cardiac catheterization in children who underwent pulmonary balloon valvuloplasty Objectives: In this study, we aimed to share our clinical experience and evaluate the results of the pulmonary balloon valvuloplasty procedure in patients who attended our pediatric cardiology department fot the last three years. Matherial and methods: The patients who underwent pulmonary balloon valvuloplasty procedure between November 2010 and November 2013 have been included this retrospective study. There were no syndromic patients. The pulmonary balloon valvuloplasty procedure was performed by intubating the patients under general anesthesia in the catheterization laboratory. Results: Seven girls and six boys have been included this study. The mean age was was 2.9±3.74 years and the patients aged between four days and 10 years-old. There were valvular type pulmonary stenosis in ten patients, valvular and infundibular type pulmonary stenosis in three patients. Monofoil catheters were used for the procedure and the average diameter of the catheter was 12.2 mm (6-20 mm). Balloon/anulus diameter ratio was 1.21 (1.1-1.33). During cardiac cathete...

show abstract

Section: Resim 4: Hastanın Tele Görüntüsünde Pulmoner Konus Belirgin unclassified

Pulmoner balon valvüloplasti yapılan çocuklarda kalp kateterizasyonu sonuçlarının değerlendirilmesi

Çimen¹,

Arslan²,

Aslan³

et al. 2014

GenelTipDer

View full text Add to dashboard Cite

show abstract

“…It is an effective method of relieving RV outflow obstruction and the treatment of choice for pure pulmonary valve stenosis. 32 Neonates with critical pulmonary valve stenosis are severely cyanosed at birth, with a ductus-dependent pulmonary blood flow requiring PGEj infusion and often mechanical ventilation. While dilatation is frequently successful in these patients, systemic saturations may remain low initially post-dilatation requiring continued prostaglandin infusion and ventilation until the RV pressure and pulmonary vascular resistance fall.…”

Section: Perclitaneolis Balloon Valvotomymentioning

confidence: 99%

Paediatric cardiac catheterization: innovations

Laussen

et al. 1995

Can J Anaesth

View full text Add to dashboard Cite

show abstract

“…In 1974, King 3 suggested the first device for closure of atrial septal defects by means of transcatheter technique using the double umbrella system. In 1982, Kan 4 with his coauthors performed the first clinical balloon dilatation of pulmonary valve stenosis in an eight-year-old child, which ensued from Lababidi's report on successful balloon valvuloplasty for aortic stenosis. 5 In 1992, Combier 6 first reported successful closure of PDA with coils that began to be widely applied throughout the world.…”

Section: Introductionmentioning

confidence: 99%

Clinical Efficiency and Safety Analysis of Transcatheter Interventional Therapy for Compound Congenital Cardiovascular Abnormalities

Zhang

Maoqin

et al. 2007

Clinical Cardiology

View full text Add to dashboard Cite

Objective: To investigate the efficiency and safety of transcatheter interventional therapy for compound congenital cardiovascular abnormalities. Methods: From Nov 2001 to Jun 2006, a total of 36 patients (17 male, 19 female), aged 17.20 ± 10.52, with compound congenital cardiovascular abnormalities underwent transcatheter interventional procedure. These patients included 11 with perimembranous ventricular septal defect (PVSD) and patent ductus arteriosus (PDA), 8 patients with PVSD and atrial septal defect (ASD), 8 patients with ASD and PDA, 7 patients with ASD and pulmonary stenosis (PS), 1 patient with ASD and mitral stenosis(MS), 1 patient with coarctation of aorta (COA) and PDA. According to the principle of “easy first, hard second,” balloon valvuloplasties of PS or MS were performed before the closure of PVSD, and of PDA and ASD. Electrocardiogram and transthoracic echocardiogram were examined at 4 days, 1, 2, 6 and 12 months, respectively, after each procedure. Results: Transcatheter interventional therapy for compound congenital cardiovascular abnormalities was successful in all patients. Among these, 2 occluders were planted in each of 27 patients, 7 patients with ASD combined with PS and 1 patient with ASD combined with MS underwent successfully performed balloon valvuloplasty and ASD closure, 1 patient with COA combined with PDA underwent successfully performed balloon valvuloplasty and subsequent covered stent implantation. No patient encountered serious adverse events during the (30.5 ± 14.6) months of follow‐up. Conclusions: Transcatheter interventional therapy for compound congenital cardiovascular abnormalities could obtain satisfactory results with technical feasibility. Copyright © 2007 Wiley Periodicals, Inc.

show abstract

Percutaneous Balloon Valvuloplasty: A New Method for Treating Congenital Pulmonary-Valve Stenosis

Cited by 660 publications

References 10 publications

Pulmoner balon valvüloplasti yapılan çocuklarda kalp kateterizasyonu sonuçlarının değerlendirilmesi

Pulmoner balon valvüloplasti yapılan çocuklarda kalp kateterizasyonu sonuçlarının değerlendirilmesi

Paediatric cardiac catheterization: innovations

Clinical Efficiency and Safety Analysis of Transcatheter Interventional Therapy for Compound Congenital Cardiovascular Abnormalities

Contact Info

Product

Resources

About